Hero Image
24 September 2024 - 8 October 2024
Osaka, Japan
EU-Japan Biotech & Pharma Partnering Conference 2024
Register now
Open until 30 September 2024

EU-Japan Biotech & Pharma Partnering Conference 2024

  

Online Event from 24-27 September 2024 

  • Online Partnering
  • Cluster / Ecosystems Presentations

Onsite Event on 7 October 2024 in Osaka

    • Onsite Partnering
    • Luncheon Session
    • Poster Display 
    • Reception including Short Pitch Session

    Site visit on 8 October morning

    • Visit of Nakanoshima Qross, an international hub for future medical care
      (The schedule of the day is here)


    The EU-Japan Biotech & Pharma Partnering Conference 2024 offers business contacts to industry professionals looking for potential partners in the Biotech and Pharma sector.


    The main element in this Conference is 1:1 partnering. All meetings will be scheduled in advance via this online platform.
    The online sessions from 24 to 27 September will have meetings arranged in the form of video calls, which can be made directly via this partnering platform without the need for any additional software.
    The on-site event will be held on 7 October at the Hotel Hankyu International in downtown Osaka. Please note that sessions at the Osaka event will be held onsite only. No online option will be provided for these. Participants can choose whether they participate in the online sessions in September only, or if they will be in Osaka for the on-site event as well. 

    The event is co-organised by the Osaka Prefectural Government, the EU-Japan Centre for Industrial Cooperation and the Enterprise Europe Network. It will be supported by various Bioclusters from Japan and Europe.

    Registered users will have access to other participants' personal and company profiles as well as assets products and technologies. Organisers will review registrants' profiles and only accept them if they:

    • are eligible for application following the below criteria
    • fitting the event's target fields mentioned below
    • are complete and allow to understand the company's purpose and its participation goals

    Only those whose registration has been authorised through event organisers will be eligible to participate in this event. 

    The event timeline

    3 June
    10:00(CET) -

    7 June
    3:00(CET)
    Registration - Pre Open for European participants
    17 June

    Registration - Open for all participants
    Including Japanese companies and organisations
    20 September

    Poster Display & Short Pitch Session & Site Visit in Osaka Deadline    

    • For Poster Display & Short Pitch Session at the Onsite Event in Osaka on 7 October
    • For patticipation in the Site Visit in Osaka on 8 October
    24 - 27 SeptemberOnline Event
    daily Online Partnering Sessions
    • 9:00 (CET)/16:00 (JST) - 12:00 (CET)/19:00 (JST)
    • 6 slots per day, 30-minutes each
    • Online presentation by European and Japanese clusters see Agenda for details
    30 September

    Registration Deadline
    * already registered participants can continue to request meetings for the On-site Partnering Sessions in Osaka on 7 Oct. 
    7 OctoberOn-site Event in Osaka

    • 10:00-17:00 (JST) Partnering
    • 10 partnering slots, 25-minutes each
    • 12:40–13:50 Lunchon Session
    • Poster Display 
    • 17:00-19:00 (JST) Reception - Including Short Pitch Sessions
    8 October

    Site visit in Osaka

    • Visit of Nakanoshima Qross (TBD), an international hub for future medical care
    • More details to come later

    Eligibility

    Access to this platform is reserved for representatives of enterprises, research and educational institutions and other related organisations, that are active in the below target fields and located in the European Union, Iceland, Norway, Liechtenstein, Albania, Bosnia and Herzegovina, Kosovo,  Montenegro, North Macedonia, Serbia, Türkiye, Moldova and Ukraine or Japan. (as of June 2024)

    Target fields of the event

    1. Drug discovery
    2. Drug discovery support including AI-assisted drug development
    3. Regenerative medicine
    4. Digital Therapeutics such as drug-device combinations, non-pharmacological therapy systems

    Cost

    Free of charge